IonQ’s Quantum Paradox: Record Revenue and Federal Cash Fuel a Rally, Even as 24% of Shares Are Shorted

IonQ shares rally 23% despite 24% short interest, driven by $2B CHIPS Act quantum funding, 755% revenue growth, and SkyWater acquisition approval.

The quantum computing sector is enjoying a moment of unprecedented political and financial momentum, and IonQ finds itself at the epicenter of a fierce tug-of-war between optimists and skeptics. Nearly a quarter of its stock — 24% — is now held short, a level that signals deep conviction among bears that the company’s $23 billion valuation has run ahead of reality. Yet the same week that figure emerged, IonQ shares rallied roughly 23%, propelled by a landmark federal funding announcement and a blockbuster earnings report that showed revenue more than octupling year over year.

The catalyst for the latest surge came from Washington, where the Trump administration committed over $2 billion from the CHIPS and Science Act specifically to quantum computing. The Department of Commerce named nine direct beneficiaries: IBM securing $1 billion, GlobalFoundries $375 million, and smaller players like Rigetti and D-Wave receiving up to $100 million each. IonQ was conspicuously absent from that first list, but investors interpreted the broad policy signal as a validation of the entire quantum ecosystem. The stock jumped more than 12% on the news alone, and the rally extended as traders bet that IonQ would eventually capture spillover benefits from the government’s strategic push.

Operationally, the company delivered numbers that made the rally easier to justify. First-quarter revenue hit $64.7 million, a 755% increase from the prior year’s $7.6 million and roughly 30% above analyst expectations. Management promptly raised its full-year 2026 guidance to a range of $265 million to $270 million, up from an earlier forecast of $260–$270 million. The growth story, however, comes with a persistent cost problem: the non-GAAP loss per share widened to $0.34, missing consensus estimates of $0.26. That bottom-line miss has done little to cool enthusiasm, partly because the company’s backlog — remaining performance obligations — stands at a robust $470 million, providing unusually high revenue visibility for a pre-profitable enterprise.

Institutional investors are voting with their feet. The proportion of shares held by professional funds has risen to 41.4%, with notable moves including Handelsbanken Fonder AB boosting its stake by 41.5% in the fourth quarter, Resona Asset Management entering as a new holder, and Banque Cantonale Vaudoise increasing its position by over 873% to 28,277 shares. These accumulations suggest that long-term money sees beyond the near-term loss and the steep price-to-sales ratio of roughly 193 times this year’s expected revenue.

Adding to the narrative, IonQ’s proposed $1.8 billion acquisition of SkyWater Technology has received shareholder approval, a move that would give the quantum firm its own semiconductor fabrication capabilities and reduce reliance on external foundries. The deal, combined with an existing strategic partnership with Nvidia — which recently deepened its quantum computing commitment through open-source tools and new interconnect technology — positions IonQ as a vertically integrated player in a market forecast to reach $35 billion within a decade.

Technically, the stock closed the week near $63.54 after touching $66, with unusually high volume. The next major resistance sits at $68.63, which coincides with the average analyst price target; the consensus range runs from $68.63 to $85.00, with ratings clustering around “Moderate Buy” and “Outperform.” On the downside, the 30-week exponential moving average provides a key support level should the short sellers decide to press their bets. The next concrete test for the company will come on August 5, 2026, when second-quarter results are due. By then, the question will be whether IonQ can convert political tailwinds and a swelling order book into the kind of commercial progress that justifies both its ambitious valuation and the heavy short interest arrayed against it.